IS
IS · IS · IS-EU/1/20/1452/002
Reblozyl
ATC B03XA06
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG*
CountryIS (IS)
ATC codeB03XA06
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Stungulyfsstofn, lausn",
"source": "lyfjastofnun",
"atc_raw": "B03XA06",
"marketed": false,
"strength": "75 mg",
"ma_number": "EU/1/20/1452/002",
"substance": "Luspaterceptum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í blóðsjúkdómum og krabbameinslækningum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "44007"
}Related drugs
Other records sharing ATC code B03XA06.
- 🇺🇸ReblozylCelgene Corporation
- DKReblozylBristol-Myers Squibb Pharma EEIG
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- PLReblozylBristol-Myers Squibb Pharma EEIG
- PLReblozylBristol-Myers Squibb Pharma EEIG
- NOReblozylBristol-Myers Squibb Pharma EEIG (1)
- DKReblozylBristol-Myers Squibb Pharma EEIG
- 🇺🇸ReblozylCelgene Corporation
Access this data programmatically
Query Reblozyl and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.